Company profile: Linkage Biosciences
1.1 - Company Overview
Company description
- Provider of molecular diagnostic products that improve and expedite complex genetic testing, initially focused on diagnostic products for solid organ and hematopoietic stem cell transplantation, including human leukocyte antigen testing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Linkage Biosciences
Parse Biosciences
HQ: United States
Website
- Description: Provider of single-cell sequencing kits and data analysis software for researchers, including Evercode Whole Transcriptome (instrument-free, scalable from thousands to millions of cells), Evercode Immune Profiling (TCR/BCR sequencing), CRISPR Detect (gRNA plus gene expression in up to one million cells), Gene Capture (targeted scRNA-seq panels), and software integrating with NGS platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parse Biosciences company profile →
Stoke Therapeutics
HQ: United States
Website
- Description: Provider of antisense oligonucleotide therapies that modulate RNA splicing to increase gene expression. Offerings include STK-001, in clinical testing for Dravet syndrome to boost protein from the healthy gene; STK-002 for autosomal dominant optic atrophy to elevate OPA-1; and the TANGO platform to increase protein from healthy genes across diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stoke Therapeutics company profile →
Singleron
HQ: China
Website
- Description: Provider of clinical diagnosis, health management, and drug development products and services, dedicated to applying single cell analysis techniques. Holds a worldwide exclusive IP license from Yale University for a uniquely designed microfluidic single cell processing device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Singleron company profile →
Hexagon Bio
HQ: United States
Website
- Description: Provider of data-driven biotech solutions developing targeted small molecule therapeutics, including drug-target prediction via the TICker algorithm to identify microbial secondary metabolites that inhibit cancer-related proteins; DNA sequencing to build the world's largest database of microbial genomes and metabolites; compound production via the HEx platform using heterologous expression; and ADC payloads from natural products for oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hexagon Bio company profile →
CellforCure
HQ: France
Website
- Description: Provider of advanced therapy medicinal product expertise as a key industrial and innovative player in the field.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellforCure company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Linkage Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Linkage Biosciences
2.2 - Growth funds investing in similar companies to Linkage Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Linkage Biosciences
4.2 - Public trading comparable groups for Linkage Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →